| Autor: |
Kamal Kant Jena, N Vishwanathan, G Manohar, Prashant Kumar Singh, Nayan Chakraborty |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Journal of Clinical and Preventive Cardiology, Vol 10, Iss 2, Pp 63-67 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
2250-3528 |
| DOI: |
10.4103/jcpc.jcpc_65_20 |
| Popis: |
Background: N-terminal pro-B-type natriuretic peptide (NT-proBNP) improves emergency room diagnosis and is a prognostic marker of acutely decompensated heart failure (HF) after hospitalization. We tried to assess the prognosis in heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF) using the biomarker. Methods: Patients were categorized into HFpEF (left ventricular ejection fraction [LVEF] ≥50%) (n = 102), HF with midrange EF (LVEF of 40%–49%) (n = 106), and HFrEF (LVEF ≤40%) (n = 112) as per the ESC classification of HF subtypes. Prognosis by absolute and percentage change in NT-proBNP at admission and at the 10th day of treatment was found in 3-month follow-up. Mortality after discharge was also assessed. Results: Among all HF groups, a reduction of NT-proBNP |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
